Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock

portfolio company news

Jul 27

Written By MacDougall Creative

MacDougall Creative https://www.macbiocom.com

MindMed Secures $50.0 Million Credit Facility with K2 HealthVentures

VBI Vaccines Announces Pricing of $18 Million Public Offering and $3 Million Concurrent Registered Direct Offering